Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Asfotase Alfa

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Strensiq

    02 7Strensiq

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    U.S.A
    arrow
    VMX
    Not Confirmed

    Alexion

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Disorders

    Currency : USD

    2020 Revenue in Millions : 732

    2019 Revenue in Millions : 593

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    United Kingdom
    arrow
    VMX
    Not Confirmed

    AstraZeneca

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Disorders

    Currency : USD

    2021 Revenue in Millions : 378

    2020 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    United Kingdom
    arrow
    VMX
    Not Confirmed

    AstraZeneca

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Diseases

    Currency : USD

    2022 Revenue in Millions : 958

    2021 Revenue in Millions : 378

    Growth (%) : 153

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    United Kingdom
    arrow
    VMX
    Not Confirmed

    AstraZeneca

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Diseases

    Currency : USD

    2023 Revenue in Millions : 1,152

    2022 Revenue in Millions : 958

    Growth (%) : 20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    U.S.A
    arrow
    VMX
    Not Confirmed

    Alexion Pharmaceuticals

    Asfotase Alfa

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2015 Revenue in Millions : 0

    2014 Revenue in Millions : 12

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    U.S.A
    arrow
    VMX
    Not Confirmed

    Alexion

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Disorders

    Currency : USD

    2018 Revenue in Millions : 475

    2017 Revenue in Millions : 340

    Growth (%) : 40%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    U.S.A
    arrow
    VMX
    Not Confirmed

    Alexion

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Disorders

    Currency : USD

    2016 Revenue in Millions : 210

    2015 Revenue in Millions : 12

    Growth (%) : 1,650

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    U.S.A
    arrow
    VMX
    Not Confirmed

    Alexion

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Disorders

    Currency : USD

    2019 Revenue in Millions : 593

    2018 Revenue in Millions : 475

    Growth (%) : 25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Strensiq

    Asfotase Alfa

    arrow
    VMX
    Not Confirmed

    Brand Name : Strensiq

    U.S.A
    arrow
    VMX
    Not Confirmed

    Alexion

    Asfotase Alfa

    Main Therapeutic Indication : Metabolic Disorders

    Currency : USD

    2017 Revenue in Millions : 340

    2016 Revenue in Millions : 210

    Growth (%) : 62

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF